Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. |
Ain KB, Egorin MJ, DeSimone PA. |
Thyroid. 2000 Jul;10(7):587-94. |
PMID 10958311 |
|
Down-regulation of an inhibitor of cell growth, transmembrane protein 34 (TMEM34), in anaplastic thyroid cancer. |
Akaishi J, Onda M, Okamoto J, Miyamoto S, Nagahama M, Ito K, Yoshida A, Shimizu K. |
J Cancer Res Clin Oncol. 2007 Apr;133(4):213-8. Epub 2006 Oct 28. |
PMID 17072649 |
|
Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. |
Akaishi J, Sugino K, Kitagawa W, Nagahama M, Kameyama K, Shimizu K, Ito K, Ito K. |
Thyroid. 2011 Nov;21(11):1183-9. Epub 2011 Sep 21. |
PMID 21936674 |
|
18F-FDG PET in the management of patients with anaplastic thyroid carcinoma. |
Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Kasperbauer JL, Reading CC, Hay ID, Lowe VJ. |
Thyroid. 2008 Jul;18(7):713-9. |
PMID 18630999 |
|
Expression and mutation analysis of the tyrosine kinase c-kit in poorly differentiated and anaplastic thyroid carcinoma. |
Broecker-Preuss M, Sheu SY, Worm K, Feldkamp J, Witte J, Scherbaum WA, Mann K, Schmid KW, Schott M. |
Horm Metab Res. 2008 Oct;40(10):685-91. Epub 2008 Jul 11. |
PMID 18622894 |
|
Ras oncogene mutations in thyroid tumors: polymerase chain reaction-restriction-fragment-length polymorphism analysis from paraffin-embedded tissues. |
Capella G, Matias-Guiu X, Ampudia X, de Leiva A, Perucho M, Prat J. |
Diagn Mol Pathol. 1996 Mar;5(1):45-52. |
PMID 8919545 |
|
Anaplastic thyroid carcinoma. A study of 70 cases. |
Carcangiu ML, Steeper T, Zampi G, Rosai J. |
Am J Clin Pathol. 1985 Feb;83(2):135-58. |
PMID 2578727 |
|
Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer. |
Chakravarty G, Santillan AA, Galer C, Adams HP, El-Naggar AK, Jasser SA, Mohsin S, Mondal D, Clayman GL, Myers JN. |
Exp Biol Med (Maywood). 2009 Apr;234(4):372-86. Epub 2009 Jan 28. |
PMID 19176870 |
|
Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002. |
Chen J, Tward JD, Shrieve DC, Hitchcock YJ. |
Am J Clin Oncol. 2008 Oct;31(5):460-4. |
PMID 18838882 |
|
Phase II study of combretastatin A4 phosphate (CA4P) in patients with advanced anaplastic thyroid carcinoma (ATC). |
Cooney MM, Savvides P, Agarwala S, Wang D, Flick S, Bergant S, Bhakta S, Lavertu P, Ortiz J, Remick S. |
Journal of Clinical Oncology 2006; 24: 300S. |
|
Results of combined treatment of anaplastic thyroid carcinoma (ATC). |
Derbel O, Limem S, Segura-Ferlay C, Lifante JC, Carrie C, Peix JL, Borson-Chazot F, Bournaud C, Droz JP, de la Fouchardiere C. |
BMC Cancer. 2011 Nov 1;11:469. |
PMID 22044775 |
|
Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. |
Donghi R, Longoni A, Pilotti S, Michieli P, Della Porta G, Pierotti MA. |
J Clin Invest. 1993 Apr;91(4):1753-60. |
PMID 8473515 |
|
A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer. |
Dowlati A, Robertson K, Cooney M, Petros WP, Stratford M, Jesberger J, Rafie N, Overmoyer B, Makkar V, Stambler B, Taylor A, Waas J, Lewin JS, McCrae KR, Remick SC. |
Cancer Res. 2002 Jun 15;62(12):3408-16. |
PMID 12067983 |
|
Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2. |
Esposito F, Tornincasa M, Pallante P, Federico A, Borbone E, Pierantoni GM, Fusco A. |
J Clin Endocrinol Metab. 2012 May;97(5):E710-8. Epub 2012 Mar 7. |
PMID 22399519 |
|
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. |
Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang SH, Koeffler HP. |
J Clin Invest. 1993 Jan;91(1):179-84. |
PMID 8423216 |
|
A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors. |
Fury MG, Solit DB, Su YB, Rosen N, Sirotnak FM, Smith RP, Azzoli CG, Gomez JE, Miller VA, Kris MG, Pizzo BA, Henry R, Pfister DG, Rizvi NA. |
Cancer Chemother Pharmacol. 2007 Mar;59(4):467-75. Epub 2006 Aug 1. |
PMID 16896930 |
|
Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. |
Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G. |
Am J Pathol. 2001 Mar;158(3):987-96. |
PMID 11238046 |
|
DNA copy number changes in thyroid carcinoma. |
Hemmer S, Wasenius VM, Knuutila S, Franssila K, Joensuu H. |
Am J Pathol. 1999 May;154(5):1539-47. |
PMID 10329606 |
|
N-cadherin-mediated adhesion and aberrant catenin expression in anaplastic thyroid-carcinoma cell lines. |
Husmark J, Heldin NE, Nilsson M. |
Int J Cancer. 1999 Nov 26;83(5):692-9. |
PMID 10521809 |
|
Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma. |
Jenkins RB, Hay ID, Herath JF, Schultz CG, Spurbeck JL, Grant CS, Goellner JR, Dewald GW. |
Cancer. 1990 Sep 15;66(6):1213-20. |
PMID 2400971 |
|
Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q. |
Kitamura Y, Shimizu K, Tanaka S, Ito K, Emi M. |
Genes Chromosomes Cancer. 2000 Mar;27(3):244-51. |
PMID 10679913 |
|
DNA aneuploidy in anaplastic carcinoma of the thyroid gland. |
Klemi PJ, Joensuu H, Eerola E. |
Am J Clin Pathol. 1988 Feb;89(2):154-9. |
PMID 3341277 |
|
Treatment of 37 patients with anaplastic carcinoma of the thyroid. |
Kobayashi T, Asakawa H, Umeshita K, Takeda T, Maruyama H, Matsuzuka F, Monden M. |
Head Neck. 1996 Jan-Feb;18(1):36-41. |
PMID 8774920 |
|
Epidermal growth factor receptor status in anaplastic thyroid carcinoma. |
Lee DH, Lee GK, Kong SY, Kook MC, Yang SK, Park SY, Park SH, Keam B, Park do J, Cho BY, Kim SW, Chung KW, Lee ES, Kim SW. |
J Clin Pathol. 2007 Aug;60(8):881-4. Epub 2006 Nov 1. |
PMID 17079354 |
|
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma. |
Lee JJ, Au AY, Foukakis T, Barbaro M, Kiss N, Clifton-Bligh R, Staaf J, Borg A, Delbridge L, Robinson BG, Wallin G, Hoog A, Larsson C. |
Endocr Relat Cancer. 2008 Sep;15(3):801-15. |
PMID 18753363 |
|
Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models. |
Lee JJ, Foukakis T, Hashemi J, Grimelius L, Heldin NE, Wallin G, Rudduck C, Lui WO, Hoog A, Larsson C. |
Thyroid. 2007 Apr;17(4):289-301. |
PMID 17465858 |
|
Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. |
Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu N, Kato K, Komatsu H, Ikeda K, Wakabayashi G, Masuda T. |
Cancer Sci. 2008 Feb;99(2):280-6. Epub 2008 Jan 14. |
PMID 18201269 |
|
A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. |
Mooney CJ, Nagaiah G, Fu P, Wasman JK, Cooney MM, Savvides PS, Bokar JA, Dowlati A, Wang D, Agarwala SS, Flick SM, Hartman PH, Ortiz JD, Lavertu PN, Remick SC. |
Thyroid. 2009 Mar;19(3):233-40. |
PMID 19265494 |
|
Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma. |
Nappi TC, Salerno P, Zitzelsberger H, Carlomagno F, Salvatore G, Santoro M. |
Cancer Res. 2009 Mar 1;69(5):1916-23. Epub 2009 Feb 17. |
PMID 19223553 |
|
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma. |
Nucera C, Eeckhoute J, Finn S, Carroll JS, Ligon AH, Priolo C, Fadda G, Toner M, Sheils O, Attard M, Pontecorvi A, Nose V, Loda M, Brown M. |
Clin Cancer Res. 2009 Jun 1;15(11):3680-9. Epub 2009 May 26. |
PMID 19470727 |
|
Anaplastic thyroid carcinoma. Immunocytochemical study of 32 cases. |
Ordonez NG, El-Naggar AK, Hickey RC, Samaan NA. |
Am J Clin Pathol. 1991 Jul;96(1):15-24. |
PMID 1712540 |
|
Prospective application of our novel prognostic index in the treatment of anaplastic thyroid carcinoma. |
Orita Y, Sugitani I, Amemiya T, Fujimoto Y. |
Surgery. 2011 Dec;150(6):1212-9. |
PMID 22136842 |
|
A phase II study of gefitinib in patients with advanced thyroid cancer. |
Pennell NA, Daniels GH, Haddad RI, Ross DS, Evans T, Wirth LJ, Fidias PH, Temel JS, Gurubhagavatula S, Heist RS, Clark JR, Lynch TJ. |
Thyroid. 2008 Mar;18(3):317-23. |
PMID 17985985 |
|
18F-fluorodeoxyglucose positron emission tomography and computed tomography in anaplastic thyroid cancer. |
Poisson T, Deandreis D, Leboulleux S, Bidault F, Bonniaud G, Baillot S, Auperin A, Al Ghuzlan A, Travagli JP, Lumbroso J, Baudin E, Schlumberger M. |
Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2277-85. Epub 2010 Aug 6. |
PMID 20694463 |
|
Tumors of the thyroid gland. |
Rosai J, Carcangiu ML, DeLellis RA. |
Atlas of tumor Pathology 1992, 3rd series, fascicle 5. |
|
Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer. |
Santarpia L, El-Naggar AK, Cote GJ, Myers JN, Sherman SI. |
J Clin Endocrinol Metab. 2008 Jan;93(1):278-84. Epub 2007 Nov 7. |
PMID 17989125 |
|
Detection of the H-RAS oncogene in human thyroid anaplastic carcinomas. |
Stringer BM, Rowson JM, Parkar MH, Seid JM, Hearn PR, Wynford-Thomas D, Ingemansson S, Woodhouse N, Goyns MH. |
Experientia. 1989 Apr 15;45(4):372-6. |
PMID 2651141 |
|
Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines. |
Takano T, Ito Y, Matsuzuka F, Miya A, Kobayashi K, Yoshida H, Miyauchi A. |
Oncol Rep. 2007 Sep;18(3):715-20. |
PMID 17671725 |
|
Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. |
Tallini G, Garcia-Rostan G, Herrero A, Zelterman D, Viale G, Bosari S, Carcangiu ML. |
Am J Surg Pathol. 1999 Jun;23(6):678-85. |
PMID 10366150 |
|
Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. |
Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H, Samaan NA. |
Cancer. 1990 Jul 15;66(2):321-30. |
PMID 1695118 |
|
Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment. |
Wiseman SM, Masoudi H, Niblock P, Turbin D, Rajput A, Hay J, Bugis S, Filipenko D, Huntsman D, Gilks B. |
Ann Surg Oncol. 2007 Feb;14(2):719-29. Epub 2006 Nov 10. |
PMID 17115102 |
|
Genome-wide appraisal of thyroid cancer progression. |
Wreesmann VB, Ghossein RA, Patel SG, Harris CP, Schnaser EA, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. |
Am J Pathol. 2002 Nov;161(5):1549-56. |
PMID 12414503 |
|
A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity. |
Yu W, Imoto I, Inoue J, Onda M, Emi M, Inazawa J. |
Oncogene. 2007 Feb 22;26(8):1178-87. Epub 2006 Aug 21. |
PMID 16924234 |
|